110 related articles for article (PubMed ID: 8287894)
21. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
Carli M; Afkhami-Dastjerdian S; Reader TA
J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
[TBL] [Abstract][Full Text] [Related]
22. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
Dziedzicka-Wasylewska M; Rogóz Z
Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
[TBL] [Abstract][Full Text] [Related]
23. The effect of a putative antidepressant, an O2-substituted derivative of barbitone on apomorphine induced hypomotility.
Menez JF; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(6):703-8. PubMed ID: 3809521
[TBL] [Abstract][Full Text] [Related]
24. The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.
Maj J; Klimek V; Rogóz Z; Skuza G; Sowińska H
J Neural Transm Gen Sect; 1991; 86(1):11-23. PubMed ID: 1751026
[TBL] [Abstract][Full Text] [Related]
25. Chronic antidepressant treatment increases the apomorphine-induced elevation of plasma corticosterone in rats.
Kourkoubas A; Pitoulis S; Spyraki C
J Pharm Pharmacol; 1988 Jun; 40(6):451-2. PubMed ID: 2901482
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum.
Paetsch PR; Greenshaw AJ
Mol Chem Neuropathol; 1993 Sep; 20(1):21-31. PubMed ID: 7902719
[TBL] [Abstract][Full Text] [Related]
27. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.
McManus DJ; Greenshaw AJ
Psychopharmacology (Berl); 1991; 103(2):204-8. PubMed ID: 1851308
[TBL] [Abstract][Full Text] [Related]
29. Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.
Towell A; Willner P; Muscat R
Psychopharmacology (Berl); 1986; 90(1):64-71. PubMed ID: 3094064
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
[TBL] [Abstract][Full Text] [Related]
31. The involvement of serotonin in the mechanism of central action of apomorphine.
Grabowska M
Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
[TBL] [Abstract][Full Text] [Related]
32. Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
Durlach-Misteli C; Van Ree JM
Eur J Pharmacol; 1992 Jun; 217(1):15-21. PubMed ID: 1397023
[TBL] [Abstract][Full Text] [Related]
33. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
Martin-Iverson MT; Leclere JF; Fibiger HC
Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
35. Hyposensitivity of dopamine "autoreceptors" induced by chronic administration of tricyclic antidepressants.
Serra G; Argiolas A; Fadda F; Gessa GL
Pharmacol Res Commun; 1980 Jun; 12(6):619-24. PubMed ID: 7403234
[No Abstract] [Full Text] [Related]
36. Chronic antidepressant counteracts the conditioned analgesia induced by a context previously associated with inescapable shock.
Murua VS; Molina VA
Psychopharmacology (Berl); 1991; 105(3):439-41. PubMed ID: 1798838
[TBL] [Abstract][Full Text] [Related]
37. Effect of repeated treatment with milnacipran on the central dopaminergic system.
Rogóz Z; Margas W; Dlaboga D; Góralska M; Dziedzicka-Wasylewska M; Maj J
Pol J Pharmacol; 2000; 52(2):83-92. PubMed ID: 10949109
[TBL] [Abstract][Full Text] [Related]
38. Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine.
Irifune M; Nomoto M; Fukuda T
Eur J Pharmacol; 1995 Jan; 272(1):79-85. PubMed ID: 7713153
[TBL] [Abstract][Full Text] [Related]
39. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
Zharkovskiĭ AM; Riago LK; Arro AG
Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological studies on the antagonism by antidepressants of the hypothermia induced by apomorphine.
Menon MK; Vivonia CA; Kling AS
Neuropharmacology; 1984 Feb; 23(2A):121-7. PubMed ID: 6325987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
